End Brain Cancer Initiative | Chris Elliott Fund

EBCI is a steadfast advocate on behalf of the brain tumor community in the United States & beyond. Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients. EBCI is supported by a nationally renowned Medical Advisory Board. These experts were invited to the Medical Advisory Board because of their outstanding patient care, their commitment to advanced treatments for brain cancer, and their willingness to facilitate IMMEDIATE CONNECTIONS to brain tumor experts and clinical trials. The End Brain Cancer Initiative is a 501(c)3 non-profit patient organization focused on disease education, awareness, outreach and increasing patient access. The End Brain Cancer Initiative, formerly known as the Chris Elliott Fund, is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists and clinical trial participation.